(Q34564488)

3 August 2017

1 reference

title

Nutrition and HIV infection. (English)

1 reference

3 August 2017

J Salomon

1

1 reference

3 August 2017

Truchis P De

series ordinal

2

1 reference

3 August 2017

J C Melchior

series ordinal

3

1 reference

3 August 2017

publication date

1 January 2002

1 reference

British Journal of Nutrition

3 August 2017

published in

1 reference

3 August 2017

volume

87 Suppl 1

1 reference

3 August 2017

page(s)

S111-9

1 reference

Lipodystrophy in patients naive to HIV protease inhibitors

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1079%2FBJN2001464

Energy expenditure and wasting in human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2001464

"Buffalo hump" in men with HIV-1 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2001464

Insulin sensitivity and insulin clearance in human immunodeficiency virus-infected men

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2001464

Insulin resistance implications for type II diabetes mellitus and coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2001464

Fasting hyperinsulinemia and changes in regional body composition in human immunodeficiency virus-infected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2001464

Fasting hyperinsulinemia in human immunodeficiency virus-infected men: relationship to body composition, gonadal function, and protease inhibitor use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2001464

Circulating interferon-alpha levels and hypertriglyceridemia in the acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2001464

Effects of androgen administration in men with the AIDS wasting syndrome. A randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2001464

Weight loss as a predictor of survival and disease progression in HIV infection. Terry Beirn Community Programs for Clinical Research on AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2001464

Weight loss and wasting remain common complications in individuals infected with human immunodeficiency virus in the era of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2001464

Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2001464

Changes in AIDS incidence for men who have sex with men, United States 1990-1995.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2001464

Effects of nandrolone decanoate therapy in borderline hypogonadal men with HIV-associated weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2001464

Bioelectrical impedance methods in clinical research: a follow-up to the NIH Technology Assessment Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2001464

The effect of protease inhibitors on weight and body composition in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2001464

Glutamine-antioxidant supplementation increases body cell mass in AIDS patients with weight loss: a randomized, double-blind controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2001464

A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. European-Australian Collaborative Ritonavir Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2001464

Slim disease: a new disease in Uganda and its association with HTLV-III infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2001464

Recombinant human growth hormone in patients with HIV-associated wasting. A randomized, placebo-controlled trial. Serostim Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2001464

A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2001464

A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2001464

Short-term progressive resistance training increases strength and lean body mass in adults infected with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2001464

Effect of ritonavir on lipids and post-heparin lipase activities in normal subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2001464

Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2001464

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2001464

Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2001464

Effect of indinavir on HIV-related wasting

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2001464

Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2001464

Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2001464

Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2001464

Differential effect of ritonavir and indinavir on immune response to hepatitis C virus in HIV-1 infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2001464

Effects of testosterone replacement with a nongenital, transdermal system, Androderm, in human immunodeficiency virus-infected men with low testosterone levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2001464

Impact of tuberculosis on the body composition of HIV-infected men in Brazil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2001464

Oxandrolone in AIDS-wasting myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2001464

Megestrol acetate in patients with AIDS and cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2001464

Comparison of methods for assessing nutritional status in HIV-infected adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2001464

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2001464

Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2001464

Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2001464

The slim disease in African patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2001464

Home parenteral nutrition in acquired immunodeficiency syndrome patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2001464

Reversion of metabolic abnormalities after switching from HIV-1 protease inhibitors to nevirapine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2001464

Measurement of Body Composition in People with HIV/AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FBJN2001464

21 January 2018

Identifiers

DOI

10.1079/BJN2001464

1 reference

3 August 2017

1 reference